39 more drugs come under price control in India
17-Jul-15, The Hindu
India has extended price control on 39 more medicines used to treat diseases such as diabetes, infections, digestive disorders and pain among others, in an effort to make them affordable.
%20The%20Hindu.jpg "39 more drugs come under price control in India (c) The Hindu")
Image: The Hindu
“These drugs, which are put under the scanner, have a market size of around Rs.1,054 crore. The reduction in the price ranges from 5-40 per cent, depending upon drug category,” Sarabjit Kour Nangra, Vice-President Research-Pharma, Angel Broking, said.
Some of the medicines are made by multi-national firms such as Abbott Laboratories and GlaxoSmithKline Plc, and some by domestic firms such as Lupin Ltd and Sun Pharmaceuticals.
Already, 652 medicines are under price control.